Design Therapeutics, Inc. (DSGN)

Design Therapeutics Statistics

Total Valuation

DSGN has a market cap or net worth of $625.97 million. The enterprise value is $408.90 million.

Market Cap	625.97M
Enterprise Value	408.90M

Important Dates

The last earnings date was Monday, March 9, 2026, after market close.

Earnings Date	Mar 9, 2026
Ex-Dividend Date	n/a

Share Statistics

DSGN has 61.67 million shares outstanding. The number of shares has increased by 1.31% in one year.

Current Share Class	61.67M
Shares Outstanding	61.67M
Shares Change (YoY)	+1.31%
Shares Change (QoQ)	+3.13%
Owned by Insiders (%)	14.44%
Owned by Institutions (%)	42.65%
Float	29.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.89
P/TBV Ratio	2.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.14, with a Debt / Equity ratio of 0.01.

Current Ratio	17.14
Quick Ratio	16.97
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.70% and return on invested capital (ROIC) is -21.56%.

Return on Equity (ROE)	-30.70%
Return on Assets (ROA)	-20.66%
Return on Invested Capital (ROIC)	-21.56%
Return on Capital Employed (ROCE)	-37.09%
Weighted Average Cost of Capital (WACC)	13.20%
Revenue Per Employee	n/a
Profits Per Employee	-$1.29M
Employee Count	54
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +116.24% in the last 52 weeks. The beta is 1.63, so DSGN's price volatility has been higher than the market average.

Beta (5Y)	1.63
52-Week Price Change	+116.24%
50-Day Moving Average	10.18
200-Day Moving Average	7.24
Relative Strength Index (RSI)	46.67
Average Volume (20 Days)	271,872

Short Selling Information

The latest short interest is 1.74 million, so 2.82% of the outstanding shares have been sold short.

Short Interest	1.74M
Short Previous Month	1.80M
Short % of Shares Out	2.82%
Short % of Float	5.95%
Short Ratio (days to cover)	8.40

Income Statement

Revenue	n/a
Gross Profit	-59.13M
Operating Income	-79.07M
Pretax Income	-69.79M
Net Income	-69.79M
EBITDA	-78.45M
EBIT	-79.07M
Earnings Per Share (EPS)	-$1.22

Balance Sheet

The company has $219.85 million in cash and $1.54 million in debt, with a net cash position of $218.31 million or $3.54 per share.

Cash & Cash Equivalents	219.85M
Total Debt	1.54M
Net Cash	218.31M
Net Cash Per Share	$3.54
Equity (Book Value)	212.50M
Book Value Per Share	3.52
Working Capital	210.73M

Cash Flow

In the last 12 months, operating cash flow was -$54.36 million and capital expenditures -$193,000, giving a free cash flow of -$54.55 million.

Operating Cash Flow	-54.36M
Capital Expenditures	-193,000
Depreciation & Amortization	622,000
Net Borrowing	n/a
Free Cash Flow	-54.55M
FCF Per Share	-$0.88

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DSGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.31%
Shareholder Yield	-1.31%
Earnings Yield	-11.13%
FCF Yield	-8.70%

Analyst Forecast

The average price target for DSGN is $15.25, which is 50.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.25
Price Target Difference	50.25%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-34.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1